Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

Study to Evaluate Safety, Tolerability, and Efficacy of GS-0976 in Adults With Nonalcoholic Steatohepatitis

ClinicalTrials.gov ID: NCT02856555

Public ClinicalTrials.gov record NCT02856555. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 17, 2026, 9:54 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Safety, Tolerability, and Efficacy of GS-0976 in Subjects With Nonalcoholic Steatohepatitis

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The primary objective of this study is to evaluate the safety and tolerability of firsocostat in adults with nonalcoholic steatohepatitis (NASH).

Study identification

NCT ID
NCT02856555
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Gilead Sciences
Industry
Enrollment
127 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years to 75 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Aug 8, 2016 (Actual)
Primary completion
Jul 18, 2017 (Actual)
Completion
Jul 18, 2017 (Actual)
Last update posted
Jul 24, 2020

2016 – 2017

United States locations

U.S. sites
36
U.S. states
17
U.S. cities
30
Facility City State ZIP Site status
Not listed Coronado California 92118 —
Not listed Foster City California 94404 —
Not listed Los Angeles California 90036 —
Not listed Los Angeles California 90048 —
Not listed Rialto California 92377 —
Not listed San Diego California 92103 —
Not listed San Diego California 92123 —
Not listed San Francisco California 94115 —
Not listed San Francisco California 94143 —
Not listed Miami Florida 33136 —
Not listed Miami Florida 33165 —
Not listed Atlanta Georgia 30308 —
Not listed Chicago Illinois 60611 —
Not listed Indianapolis Indiana 46202 —
Not listed New Orleans Louisiana 70112 —
Not listed Boston Massachusetts 02115 —
Not listed Rochester Minnesota 55905 —
Not listed Kansas City Missouri 64131 —
Not listed New York New York 10016 —
Not listed Durham North Carolina 27710 —
Not listed Statesville North Carolina 28677 —
Not listed Philadelphia Pennsylvania 19707 —
Not listed Pittsburgh Pennsylvania 15213 —
Not listed Germantown Tennessee 38138 —
Not listed Memphis Tennessee 38104 —
Not listed Nashville Tennessee 37211 —
Not listed Arlington Texas 76012 —
Not listed Live Oak Texas 78233 —
Not listed San Antonio Texas 78215 —
Not listed Murray Utah 84107 —
Not listed Falls Church Virginia 22042 —
Not listed Richmond Virginia 23226 —
Not listed Richmond Virginia 23249 —
Not listed Richmond Virginia 23298 —
Not listed Richland Washington 99352 —
Not listed Seattle Washington 98104 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02856555, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jul 24, 2020 · Synced Oct 17, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT02856555 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →